HPLC testing for thalassemia is a blood test that separates and measures different types of hemoglobin, the protein in red blood cells that carries oxygen. The pattern can help identify beta-thalassemia carriers and some forms of thalassemia or other hemoglobin conditions. Results are usually reviewed with a complete blood count and medical history. HPLC alone may not detect every type, especially some forms of alpha-thalassemia.
What is HPLC testing for thalassemia?
High-performance liquid chromatography (HPLC) is a laboratory method used to separate and measure the different types of hemoglobin in a blood sample. Hemoglobin is the protein inside red blood cells that carries oxygen throughout the body. In thalassemia, inherited changes affect how much of certain hemoglobin components the body produces.
HPLC helps laboratories examine the proportions of different hemoglobin types, which are commonly reported as percentages. The resulting pattern can provide important clues about whether someone may carry a thalassemia gene variant or have a form of the condition. It can also help identify other inherited hemoglobin disorders.
According to the UK Department of Health and Social Care's laboratory screening guidance, HPLC is an accepted method for measuring hemoglobin A2 (HbA2) and screening for hemoglobin variants. However, screening results may require confirmation using another laboratory method or genetic testing.
Why is HPLC recommended when thalassemia is suspected?
A healthcare professional may recommend HPLC when routine blood tests suggest that hemoglobin production could be affected. The test is useful because a complete blood count alone cannot reliably distinguish thalassemia from every other cause of anemia or unusually small red blood cells.
Common reasons for ordering the test include:
- A complete blood count showing smaller-than-usual red blood cells or low hemoglobin levels.
- Suspected beta-thalassemia trait or another inherited hemoglobin disorder.
- A family history of thalassemia or a previously identified hemoglobin variant.
- Carrier screening before pregnancy or during antenatal care.
- Further investigation of anemia when initial blood test results do not explain the findings.
The National Heart, Lung, and Blood Institute (NHLBI) explains that thalassemia evaluation may include a complete blood count, specialized hemoglobin tests, and genetic testing. These tests provide different kinds of information and are interpreted together when needed.
How does the HPLC test work?
HPLC uses a laboratory column containing a material that separates hemoglobin components as the blood sample passes through under controlled conditions. A changing liquid mixture, called a buffer, helps the different components emerge from the column at different times. A detector measures the hemoglobin as it passes through, allowing the laboratory to identify and estimate the proportion of individual fractions.
The laboratory typically produces a graph called a chromatogram. Peaks on this graph represent detected components, and the report may include their names, percentages, or other measurements. The position and size of these peaks help laboratory specialists recognize patterns associated with different hemoglobin conditions.
Not every hemoglobin variant produces a uniquely identifiable result on every HPLC system. Some variants can appear in the same detection region, making additional testing necessary. HPLC findings must therefore be interpreted using the laboratory's method, quality standards, and the patient's other clinical information.
Which hemoglobin types does HPLC measure?
Hemoglobin is made up of different components, and their proportions vary with age and inherited characteristics. HPLC commonly evaluates the following fractions when the laboratory method can measure them reliably.
Hemoglobin A (HbA)
HbA is the main hemoglobin type in most healthy adults. Its proportion may change in certain inherited hemoglobin disorders. The amount detected must be considered alongside other fractions because a single HbA result cannot establish or exclude thalassemia.
Hemoglobin A2 (HbA2)
HbA2 is a minor hemoglobin component that is particularly useful when evaluating possible beta-thalassemia trait. An HbA2 level above the laboratory's reference range may support this possibility, especially when the complete blood count also shows small red blood cells. The finding is not conclusive by itself, and the appropriate cutoff depends on the laboratory method and clinical circumstances.
Hemoglobin F (HbF)
HbF, also called fetal hemoglobin, is the main hemoglobin type before birth and remains present in varying amounts during early childhood. In some forms of beta-thalassemia, HbF may be higher than expected for the person's age. Its significance depends on the age of the individual and the pattern of the other hemoglobin fractions.
Other hemoglobin variants
Depending on the laboratory method, HPLC may also detect hemoglobin variants such as HbS or HbE. These findings can help identify other inherited blood conditions or combinations of hemoglobin disorders. A variant's presence and proportion do not always establish the exact diagnosis, so further analysis may be required.
How are HPLC results interpreted?
An HPLC report describes the hemoglobin fractions identified in the sample and their relative amounts. There is no single result that can be used to diagnose every type of thalassemia. The overall pattern, the complete blood count, iron status, age, family history, and any previous transfusions may all affect the interpretation.
Raised HbA2 levels
An increased HbA2 level can be an important clue to beta-thalassemia trait, also called beta-thalassemia minor. People with this carrier state may have small red blood cells and sometimes mild anemia, while others have no noticeable symptoms. A healthcare professional reviews the HbA2 result alongside the blood count and other findings before confirming carrier status.
Increased HbF levels
An increased HbF level may occur in certain forms of beta-thalassemia and in other inherited hemoglobin conditions. The degree of increase varies, and HbF is naturally higher in newborns than in older children and adults. For this reason, age-appropriate reference ranges are important, particularly when interpreting results in infants.
Results that do not clearly show beta-thalassemia
A report without a clearly raised HbA2 level does not exclude every form of thalassemia. Alpha-thalassemia trait, for example, may not produce a distinctive pattern on routine HPLC testing. If the blood count and clinical history continue to suggest an inherited condition, a healthcare professional may recommend additional laboratory investigations or molecular genetic testing.
The MedlinePlus Medical Encyclopedia notes that hemoglobin testing can help identify beta-thalassemia, while mutational analysis may help detect alpha-thalassemia. This illustrates why a normal or inconclusive hemoglobin analysis sometimes needs further investigation.
How are HbA2 results reported?
Laboratories report HbA2 as a percentage of the total measured hemoglobin or according to the reporting format of their testing system. Some screening programmes use a value around 3.5% as an important threshold for further assessment of possible beta-thalassemia carrier status. This is not a universal diagnostic cutoff, however. The reference interval, analytical method, presence of other hemoglobin variants, and associated blood count findings all matter.
Iron deficiency and certain other medical conditions may complicate the interpretation of HbA2. When the findings are borderline or do not fit together, the clinician may assess iron stores and consider repeat or additional testing rather than relying on a single number.
Can HPLC detect all types of thalassemia?
No. HPLC is a useful tool for hemoglobin analysis, but its ability to identify a particular condition depends on the type of thalassemia, the hemoglobin fractions present, and the capabilities of the laboratory system.
Beta-thalassemia trait often produces a characteristic pattern, including raised HbA2. In contrast, some alpha-thalassemia carrier states may have normal-looking hemoglobin fractions. More complex combinations of thalassemia and other hemoglobin variants can also make the results harder to interpret.
If HPLC does not provide a clear answer, the next step may include capillary electrophoresis, another appropriate hemoglobin analysis method, or molecular testing. Genetic testing can help identify specific changes in the genes involved in hemoglobin production. The choice depends on the suspected condition and whether the result is needed for clinical diagnosis or reproductive counselling.
How should you prepare for HPLC testing?
HPLC testing usually requires a blood sample collected from a vein in the arm. Special preparation or fasting is not generally needed for hemoglobin analysis, but you should follow any instructions given by the laboratory or healthcare professional arranging your test.
Before the sample is collected, tell your healthcare professional about any previous blood transfusions, including when the most recent transfusion took place. Transfused red blood cells can affect the hemoglobin pattern and may produce results that do not accurately reflect your own hemoglobin production. Also mention any history of bone marrow or stem cell transplantation or gene therapy, since these can be relevant to interpretation.
It is helpful to bring previous complete blood count reports, hemoglobin analysis results, and relevant family medical information. These details can help the clinician compare the HPLC findings with earlier results and decide whether any follow-up testing is needed.
What happens after an abnormal HPLC result?
An abnormal result does not automatically mean that someone has a clinically significant form of thalassemia. The next step depends on which hemoglobin fractions were found, their percentages, and the rest of the blood test results.
A healthcare professional may compare the HPLC report with a complete blood count, blood film, and iron studies. Additional hemoglobin analysis or genetic testing may be recommended if the pattern is unclear or if an alpha-thalassemia carrier state is suspected.
When testing identifies a possible inherited carrier state, reproductive counselling may be useful, particularly before or during pregnancy. If one biological parent carries a significant hemoglobin gene variant, testing the other parent may help clarify the chance of a child inheriting an affected combination.
The NHS guidance on thalassemia diagnosis describes blood testing for people who may be carriers and the role of testing in pregnancy. Results should be discussed with a qualified healthcare professional who can explain their significance and whether further investigation is appropriate.
What are the limitations of HPLC testing?
Although HPLC provides detailed information about hemoglobin, several factors can affect the reliability or interpretation of the report. Some hemoglobin variants overlap during analysis, certain carrier states may not be clearly visible, and recent transfusions can change the proportions detected. In some situations, a second method or genetic testing is necessary to clarify the findings.
The UK Department of Health and Social Care's guidance on interpreting screening results explains that hemoglobin variants may overlap on screening systems and that recent transfusions can lead to misleading conclusions. This is one reason laboratories may describe initial findings as provisional and recommend further investigation when appropriate.
HPLC also does not measure the body's iron stores. When anemia or small red blood cells are present, separate tests may be needed to investigate iron deficiency or other causes. The most useful interpretation comes from considering all relevant results together rather than treating the HPLC report as a stand-alone diagnosis.